S. CROS
Impact in
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Metal complexes synthesis and properties
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents
Papers in ⓘ
-
- Cancer therapeutics and mechanisms 8
-
- Synthesis and Biological Evaluation 3
- Synthesis and biological activity 3
- Synthesis and Reactions of Organic Compounds 2
- Co-authors
- Matthew C. Wright (1 shared paper)M. Morimoto (1 shared paper)A Krikorian (1 shared paper)J. P. Couzinier (1 shared paper)Bernard Monsarrat (3 shared papers)Claude Paoletti (4 shared papers)Daniel Guénard (1 shared paper)Françoise Guéritte-Voegelein (1 shared paper)
- Journals
- Drug Metabolism and Disposition (2 papers)Toxicology and Applied Pharmacology (1 paper)JNCI Journal of the National Cancer Institute (1 paper)Biochimie (1 paper)Journal of Organometallic Chemistry (1 paper)
- Partner nations
- France
In The Last Decade
S. CROS
26 papers receiving 562 citations
Peers
Comparison fields: 5 of 88
- Oncology 325
- Toxicology 30
- Pharmacology 76
- Organic Chemistry 146
- Molecular Biology 248
Countries citing papers authored by S. CROS
This map shows the geographic impact of S. CROS's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. CROS with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. CROS more than expected).
Fields of papers citing papers by S. CROS
This network shows the impact of papers produced by S. CROS. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. CROS. The network helps show where S. CROS may publish in the future.
Co-authors
The 25 scholars most cited alongside S. CROS, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Experimental antitumor activity of Navelbine. | 1989 | 117 |
| 2 | 1990 | 102 | |
| 3 | 1967 | 58 | |
| 4 | Preclinical antitumor activity of a new Vinca alkaloid derivative, S 12363. | 1991 | 44 |
| 5 | 1991 | 42 | |
| 6 | Antitumor activity of 9-hydroxyellipticine (NSC 210717) ON L1210 mouse leukemia and the effect of route of injection. | 1976 | 34 |
| 7 | The antitumor activity of some palladium(II) complexes with chelating ligands. | 1989 | 33 |
| 8 | Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HCl. | 1987 | 31 |
| 9 | 1988 | 28 | |
| 10 | 1978 | 19 | |
| 11 | 2012 | 18 | |
| 12 | 1975 | 15 | |
| 13 | Synthesis, antitumor evaluation and SAR of new 1H-pyrrolo [3,2-c] quinoline-6,9-diones and 11H-indolo [3,2-c] quinoline-1,4-diones. | 1994 | 12 |
| 14 | 1981 | 9 | |
| 15 | Heterocyclic quinones. VI: Synthesis and antitumoral effects of 5,10-benzo [g] quinoxalinediones and aza-analogues | 1985 | 8 |
| 16 | [Tetramethylurea action on the embryonic development of the mouse]. | 1972 | 6 |
| 17 | 1985 | 4 | |
| 18 | [Studies on the toxicity of 9-hydroxyellipticine]. | 1974 | 3 |
| 19 | 1994 | 3 | |
| 20 | 1980 | 3 |
About S. CROS
S. CROS is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Toxicology and Immunology, having authored 26 papers that have together received 598 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (8 papers), Cancer Treatment and Pharmacology (5 papers), Synthesis and Biological Evaluation (3 papers), Toxin Mechanisms and Immunotoxins (3 papers), Synthesis and biological activity (3 papers), Bioactive Compounds and Antitumor Agents (3 papers), Lung Cancer Research Studies (2 papers) and Synthesis and Reactions of Organic Compounds (2 papers). The work is most often cited by research in Oncology (325 citations), Toxicology (30 citations), Pharmacology (76 citations), Organic Chemistry (146 citations) and Molecular Biology (248 citations). S. CROS has collaborated with scholars based in France. Frequent co-authors include Matthew C. Wright, M. Morimoto, A Krikorian, J. P. Couzinier, Bernard Monsarrat, Claude Paoletti, Daniel Guénard, Françoise Guéritte-Voegelein, Mark D. Wright and Neil P. Johnson. Their work appears in journals such as Drug Metabolism and Disposition, Toxicology and Applied Pharmacology, JNCI Journal of the National Cancer Institute, Biochimie and Journal of Organometallic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.